StockData
Kyverna Therapeutics, Inc. logo

Kyverna Therapeutics, Inc. (KYTX) stock

KYTXNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Số liệu tài chính tới Q3 năm tài chính 2026, quý kết thúc ngày Sep 30, 2026Last filing: 10-Q on Nov 12, 2026Score 2/30
$4.48−0.22 (-4.68%)

Close on Nov 18, 2026Market cap $277.06MP/E –Yield –

Kyverna Therapeutics enterprise value

Enterprise value is market cap plus debt, minus cash: the value of the whole business to all its investors.

Kyverna Therapeutics's enterprise value was $140.72M on Nov 11, 2026, against $164.80M a year earlier. Over the last 3 years it ranged from -$202.60M to $347.29M, with a median of $3.58M.

Enterprise Value at the end of each year

PeriodPeriod endValueChange
2026Nov 11, 2026$140.72M-41.5%
2025Dec 31, 2025$240.56M–
2024Dec 31, 2024-$160.15M–

More Kyverna Therapeutics figures

See a number that looks wrong?